Cohen, Jennifer
Duong, Son Q.
Arivazhagan, Naveen
Barris, David M.
Bebiya, Surkhay
Castaldo, Rosalie
Gayanilo, Marjorie
Hopkins, Kali
Kailas, Maya
Kong, Grace
Ma, Xiye
Marshall, Molly
Paul, Erin A.
Tan, Melanie
Yau, Jen Lie
Nadkarni, Girish N.
Ezon, David
Article History
Received: 15 January 2024
Accepted: 23 April 2024
First Online: 10 May 2024
Declarations
:
: David Ezon is CEO of Tapestry Insight, Inc. Girish Nadkarni reports consultancy agreements with AstraZeneca, BioVie, GLG Consulting, Pensieve Health, Reata, Renalytix, Siemens Healthineers and Variant Bio; research funding from Goldfinch Bio and Renalytix; honoraria from AstraZeneca, BioVie, Lexicon, Daiichi Sankyo, Menarini Health and Reata; patents or royalties with Renalytix; owns equity and stock options in Pensieve Health and Renalytix as a scientific cofounder; owns equity in Verici Dx; has received financial compensation as a scientific board member and advisor to Renalytix; serves on the advisory board of Neurona Health; and serves in an advisory or leadership role for Pensieve Health and Renalytix. No other authors report competing interests.